Publications by authors named "Sara Erber"

Claim this Profile
H
HDAC Screening Identifies the HDAC Class I Inhibitor Romidepsin as a Promising Epigenetic Drug for Biliary Tract Cancer.
Christian Mayr, Tobias Kiesslich, Sara Erber, Dino Bekric, Heidemarie Dobias

Cancers (Basel)ยท July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis